Cargando…

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma

BACKGROUND: The management of patients with advanced stages of head and neck cancer requires a multidisciplinary and multimodality treatment approach which includes a combination of surgery, radiation, and chemotherapy. These toxic treatment protocols have significantly improved survival outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Timothy, Biron, Vincent L, Fast, David, Tam, Raymond, Carey, Thomas, Shmulevitz, Maya, Seikaly, Hadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348167/ https://www.ncbi.nlm.nih.gov/pubmed/25890191 http://dx.doi.org/10.1186/s40463-015-0062-x

Ejemplares similares

HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma
por: Xu, Caroline C, et al.
Publicado: (2013)

Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants
por: Mohamed, Adil, et al.
Publicado: (2015)

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
por: Cristi, Francisca, et al.
Publicado: (2023)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
por: Twigger, Katie, et al.
Publicado: (2012)

Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
por: Lindsay, Cameron, et al.
Publicado: (2017)

Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013)

Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
por: Kemp, Vera, et al.
Publicado: (2017)

Reovirus uses temporospatial compartmentalization to orchestrate core versus outercapsid assembly
por: Kniert, Justine, et al.
Publicado: (2022)

Genetic Modifications That Expand Oncolytic Virus Potency
por: Cristi, Francisca, et al.
Publicado: (2022)

Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis
por: Pan, Da, et al.
Publicado: (2013)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

The effect of second hand smoke in patients with squamous cell carcinoma of the head and neck
por: Idris, Sherif, et al.
Publicado: (2019)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire
por: Anderson, Scott, et al.
Publicado: (2017)

Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas
por: Lindsay, Cameron D., et al.
Publicado: (2017)

Journal of Otolaryngology – Head & Neck Surgery reviewer acknowledgement 2015
por: Seikaly, Hadi, et al.
Publicado: (2016)

Reovirus genomic diversity confers plasticity for protease utility during adaptation to intracellular uncoating
por: Lin, Qi Feng, et al.
Publicado: (2023)

Factors associated with severe deep neck space infections: targeting multiple fronts
por: Barber, Brittany R, et al.
Publicado: (2014)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
por: Chantre-Justino, Mariana, et al.
Publicado: (2022)

Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study
por: Barber, Brittany, et al.
Publicado: (2015)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

Surgical vs ultrasound-guided drainage of deep neck space abscesses: a randomized controlled trial: surgical vs ultrasound drainage
por: Biron, Vincent L, et al.
Publicado: (2013)

Survival outcomes of First Nations patients with oral cavity squamous cell carcinoma (Poliquin 2014)
por: Erickson, Bree, et al.
Publicado: (2015)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

The oncolytic effects of reovirus in canine solid tumor cell lines
por: IGASE, Masaya, et al.
Publicado: (2015)

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
por: Kemp, Vera, et al.
Publicado: (2015)

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)

A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing
por: Nichols, Anthony C., et al.
Publicado: (2012)

Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix
por: Gazzaz, Malak Jamal, et al.
Publicado: (2019)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

Journal of Otolaryngology Head & Neck Surgery – An ‘Open’ Letter to Our Authors and Readers
por: Seikaly, Hadi, et al.
Publicado: (2013)

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma
por: Callahan, S. Carson, et al.
Publicado: (2022)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jhum595sj43v1us6flvnsdumt